INSM Insmed - tpip demonstrates sustained improvement and reduced mortality risk at 12 months - Tpip safe and well-tolerated with no new saf
INSM Insmed - tpip demonstrates sustained improvement and reduced mortality risk at 12 months - Tpip safe and well-tolerated with no new safety signals through month 12
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.